Latest News - Danaher
Top Corporates Hub
Danaher
Modine Manufacturing Company (MOD): A Bull Case Theory
26.08.2025 08:12
We came across a bullish thesis on Modine Manufacturing Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on MOD. Modine Manufacturing Company’s share was trading at $138.72 as of August 15th. MOD’s trailing and forward P/E were 39.75 and 31.85, respectively according to Yahoo Finance. Modine Manufacturing is a thermal […]
AstroNova: A Textbook Case For Shareholder Activism
17.08.2025 01:45
Our AstroNova investment was predicated on the view that this was a low-risk "under-earner". So, what went wrong? Click here to find out.
Atai Capital Management Q2 2025 Letter
17.08.2025 01:20
Atai Capital Management reports a 32.8% Q2 gain, reviews key portfolio moves and lessons from past missteps. Read the full letter for insights and strategy.
Are Wall Street Analysts Predicting Danaher Stock Will Climb or Sink?
14.08.2025 15:42
After weak long-term price action, are analysts bullish or bearish on Danaher Corp stock?
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
13.08.2025 02:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision
Charles River raises profit forecast on growing demand for drug development services
06.08.2025 11:55
The Wilmington, Massachusetts-based contract drug developer raised its 2025 adjusted profit forecast to $9.90 to $10.30 per share, compared with its previous projection of $9.30 to $9.80. Contract research organizations, which reported quarterly results over the last month, have all posted better-than-expected profit, reflecting a rebound in spending from pharmaceutical and biotech clients after a cautious stretch driven by tighter sector financing. "We are continuing to see clear signs that the biopharmaceutical demand is stabilizing, and in this environment, we are making gradual progress to return to organic revenue growth," Charles River CEO James Foster said.
Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy
05.08.2025 13:00
The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...
Where this large cap portfolio manager see opportunity now
29.07.2025 08:00
Looking for a large-cap stock to invest in? In the video above, Macquarie Large Cap Growth Team senior portfolio manager Brad Klapmeyer shares some of the sectors and stocks he's taking a closer look at. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
25.07.2025 13:50
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
25.07.2025 04:32
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Danaher Stock: Attractively Valued And Poised For Growth Acceleration
23.07.2025 09:50
Danaher Corporation thrives on bioprocessing demand & diagnostics resilience. Click for why, with solid execution & 80% recurring revenue, DHR offers upside.
Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ...
23.07.2025 07:04
Danaher Corp (DHR) reports robust free cash flow and bioprocessing growth, while navigating global trade tensions and Life Sciences segment challenges.
Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings
21.07.2025 03:07
Diversified science and technology company Danaher (NYSE:DHR) will be reporting earnings this Tuesday before market hours. Here’s what to look for.
Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers
18.07.2025 14:32
The Medical Filtration Companies Quadrant offers a detailed analysis of the global medical filtration market, spotlighting key players, technological advancements, and market trends. This report categorizes the top 15 companies, including leaders like Merck KGaA, 3M, and Danaher, each excelling in areas such as healthcare and life sciences. Medical filtration is crucial for removing contaminants from fluids, ensuring safety and purity in applications like dialysis and drug delivery. Techniques i
Johnson Controls: Portfolio Transformation And Megatrends Support Re-Rating
08.07.2025 12:41
Johnson Controls trades at a premium vs. historical avg., but valuation is justified by exposure to secular growth trends and a stronger, recurring revenue mix. Learn more on JCI stock here.
Liquid Handling Systems Market Insights Report 2025-2030 | Advancements in Microplate Reagent Dispensers, Transformation in Genomics, Importance in Drug Discovery & Development, Lab Automation
08.07.2025 10:24
The Liquid Handling Systems Market is anticipated to grow from USD 4.34 billion in 2024 to USD 6.75 billion by 2030, with a CAGR of 7.64%. Key drivers include the increased focus on lab automation and its role in drug discovery. The pipettes segment leads by product share in 2024, while the manual method segment shows the highest growth. The pharma and biotech sector is the primary end-user, and North America holds the largest regional market share. Major players include Agilent Technologies, Da
Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside
30.06.2025 04:23
Danaher is positioned for a revenue rebound, led by strong bioprocessing demand and resilient recurring sales. Read why DHR stock is a Buy.
1 Industrials Stock for Long-Term Investors and 2 to Ignore
27.06.2025 04:41
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But this role also comes with a demand profile tethered to the ebbs and flows of the broader economy. Thankfully, industrial end markets were stable over the past six months as the industry’s 1.5% gain has nearly mirrored the S&P 500.
Fortive Corporation (FTV) Is A “Great” Company, Says Jim Cramer
25.06.2025 06:31
Fortive Corporation (NYSE:FTV) is one of the Jim Cramer Discusses US-China Trade War & These 10 Stocks. Fortive Corporation (NYSE:FTV) is also an industrial products company. The firm sells testing, compliance, and measurement equipment to the industrial, automotive, healthcare, and other industries. Fortive Corporation (NYSE:FTV)’s shares have lost 6.4% year-to-date, primarily on the back of […]